Demonstration of safety and efficacy for advanced therapies and other large molecule drugs requires a strategy that is as customized as the medicines themselves. The expertise we bring in pathology, mechanisms of action, and assay design are critical to ensure you get the data you need when you need it.
The spectrum of data that is possible to gather during advanced therapeutic development is broad and growing rapidly. We are expanding our assay systems, methods, and expertise to support meaningful decision-making for these drugs because, in preclinical research, the right analytics save time and loss later.